You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
Research indicates that Alzheimer's disease (AD) significantly affects visual processing capabilities, which can be linked to cognitive performance. Individuals with AD exhibit visual attention, contrast sensitivity, and motion perception impairments, all of which are crucial for cognitive tasks. Furthermore, studies have shown that visual deficits may precede cognitive decline, suggesting that assessing visual processing could provide early indicators of Alzheimer's disease.
Objective
This systematic review aims to evaluate the evidence linking visual processing deficits to early cognitive decline in Alzheimer's disease and to identify neuro‐ophthalmological tools that assess these deficits and their potential role in early diagnosis.
Methods
A systematic search was conducted across PubMed, Scopus, Embase, and Web of Science for studies published between January 2010 and December 2024. The inclusion criteria encompassed studies that examined visual processing metrics (e.g., contrast sensitivity, motion perception) in individuals diagnosed with AD or mild cognitive impairment (MCI). The selected studies were critically appraised for their quality and relevance to the research question.
Results
Twenty‐four studies met the inclusion criteria, comprising 10,211 participants. Significant deficits were observed in AD patients compared to controls: Motion Perception: The Standardized Mean Difference (SMD) was found to be ‐0.89 (95% CI: ‐1.12 to ‐0.66), indicating a significant difference in motion perception between AD patients and controls. Saccadic Eye Movements: SMD = ‐0.76 (95% CI: ‐0.94 to ‐0.58), Contrast Sensitivity: SMD = ‐0.82 (95% CI: ‐1.03 to ‐0.61), MCI patients exhibited intermediate impairments in these metrics. Importantly, visual processing deficits were found to strongly correlate with cognitive scores (r = 0.52 to 0.63, p < 0.001), providing robust evidence for the strong relationship between visual deficits and cognitive decline.
Conclusion
Visual processing deficits are consistently associated with early cognitive decline in AD and may serve as non‐invasive biomarkers for early detection. Understanding this link can aid in developing diagnostic tools for timely intervention. The need for further investigation into their clinical utility is clear, and this area of research promises to be both challenging and rewarding.
Keywords: Alzheimer's disease, mild cognitive impairment, visual processing deficits, biomarkers, systematic review
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 PSMMC, Riyadh, Saudi Arabia,





